Keqing Zhu, Chenhui Mao, Juan Du, et al. Neurodegenerative diseases pathological diagnosis in brain bank. [J]. Journal of Shanxi Agricultural Sciences 46(7):781-785(2021)
DOI:
Keqing Zhu, Chenhui Mao, Juan Du, et al. Neurodegenerative diseases pathological diagnosis in brain bank. [J]. Journal of Shanxi Agricultural Sciences 46(7):781-785(2021) DOI: 10.13406/j.cnki.cyxb.002798.
Neurodegenerative diseases pathological diagnosis in brain bank
Montine TJ, Phelps CH, Beach TG, et al. National institute on aging-Alzheimer's association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach[J]. Acta Neuropathol, 2012, 123(1):1-11.
Thal DR, Rüb U, Orantes M, et al. Phases of A beta-deposition in the human brain and its relevance for the development of AD[J]. Neurology, 2002, 58(12):1791-1800.
Lee EB, Porta S, Michael-Baer G, et al. Expansion of the classificationof FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration[J]. Acta Neuropathol, 2017, 134(1):65-78.
Levin J, Kurz A, Arzberger T, et al. The differential diagnosis and treatment of atypical Parkinsonism[J]. Dtsch Arztebl Int, 2016, 113(5):61-69.
Dickson DW, Ahmed Z, Algom AA, et al. Neuropathology of variants of progressive supranuclear palsy[J]. Curr Opin Neurol, 2010, 23(4):394-400.
Boxer AL, Yu JT, Golbe LI, et al. Advances in progressive supranuclear palsy: newdiagnosticcriteria, biomarkers, andtherapeuticapproaches[J]. Lancet Neurol, 2017, 16(7):552-563.
Dickson DW, Bergeron C, Chin SS, et al. Office of rare diseases neuropathologic criteria for corticobasal degeneration[J]. J Neuropathol Exp Neurol, 2002, 61(11):935-946.
Yoshida M. Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration[J]. Neuropathology, 2014, 34(6):555-570.
Zhang W, Tarutani A, Newell KL, et al. Novel tau filament fold in corticobasal degeneration[J]. Nature, 2020, 580(7802):283-287.
Jellinger KA, Lantos PL. Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update[J]. Acta Neuropathol, 2010, 119(6):657-667.
Trojanowski JQ, Revesz T, Neuropathology Working Group on MSA. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy[J]. Neuropathol Appl Neurobiol, 2007, 33(6):615-620.
Jellinger KA. Multiple system atrophy: an oligodendroglioneural synucleinopathy1[J]. J Alzheimers Dis, 2018, 62(3):1141-1179.
Koga S, Dickson DW. Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy[J]. J Neurol Neurosurg Psychiatry, 2018, 89(2):175-184.
Crary JF, Trojanowski JQ, Schneider JA, et al. Primary age-related tauopathy(PART): a common pathology associated with human aging[J]. Acta Neuropathol, 2014, 128(6):755-766.
Zhu K, Wang X, Sun B, et al. primary age-related tauopathy in human subcortical nuclei[J]. Front Neurosci, 2019, 13:529.
Zhang X, Sun B, Wang X, et al. phosphorylated TDP-43 staging of primary age-related tauopathy[J]. Neurosci Bull, 2019, 35(2):183-192.